Linda Moore | General Counsel |
Pam Marrone | CEO |
Jim Boyd | President and CFO |
Kevin Hammill | Chief Commercial Officer |
Ben Klieve | National Securities Corporation |
Robert Smith | Center for Performance Investing |
Good day, and welcome to the Marrone Bio Innovations Fourth Quarter and Fiscal Year 2018 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Ms. Linda Moore, General Counsel. Please go ahead, ma'am.